科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/06 | 3,635 | 3,675 | 3,620 | 3,660 | +30 | +0.8% | 87,900 |
| 2023/04/05 | 3,705 | 3,705 | 3,630 | 3,630 | -90 | -2.4% | 94,500 |
| 2023/04/04 | 3,710 | 3,720 | 3,680 | 3,720 | +30 | +0.8% | 130,200 |
| 2023/04/03 | 3,700 | 3,715 | 3,685 | 3,690 | -5 | -0.1% | 106,100 |
| 2023/03/31 | 3,715 | 3,720 | 3,685 | 3,695 | -20 | -0.5% | 76,000 |
| 2023/03/30 | 3,760 | 3,760 | 3,700 | 3,715 | -100 | -2.6% | 62,600 |
| 2023/03/29 | 3,795 | 3,830 | 3,775 | 3,815 | +35 | +0.9% | 88,100 |
| 2023/03/28 | 3,780 | 3,795 | 3,750 | 3,780 | +15 | +0.4% | 53,400 |
| 2023/03/27 | 3,770 | 3,790 | 3,740 | 3,765 | +35 | +0.9% | 78,900 |
| 2023/03/24 | 3,650 | 3,730 | 3,650 | 3,730 | +60 | +1.6% | 63,000 |
| 2023/03/23 | 3,650 | 3,685 | 3,645 | 3,670 | -15 | -0.4% | 47,500 |
| 2023/03/22 | 3,695 | 3,700 | 3,665 | 3,685 | +40 | +1.1% | 63,800 |
| 2023/03/20 | 3,660 | 3,680 | 3,635 | 3,645 | -35 | -1% | 63,600 |
| 2023/03/17 | 3,690 | 3,705 | 3,680 | 3,680 | +5 | +0.1% | 65,100 |
| 2023/03/16 | 3,650 | 3,685 | 3,635 | 3,675 | -40 | -1.1% | 77,500 |
| 2023/03/15 | 3,695 | 3,725 | 3,675 | 3,715 | +20 | +0.5% | 71,900 |
| 2023/03/14 | 3,700 | 3,715 | 3,640 | 3,695 | -50 | -1.3% | 66,100 |
| 2023/03/13 | 3,775 | 3,775 | 3,715 | 3,745 | -50 | -1.3% | 54,400 |
| 2023/03/10 | 3,780 | 3,820 | 3,780 | 3,795 | -20 | -0.5% | 92,200 |
| 2023/03/09 | 3,800 | 3,825 | 3,795 | 3,815 | +40 | +1.1% | 52,500 |
| 2023/03/08 | 3,720 | 3,790 | 3,715 | 3,775 | +50 | +1.3% | 81,000 |
| 2023/03/07 | 3,710 | 3,750 | 3,705 | 3,725 | +20 | +0.5% | 45,000 |
| 2023/03/06 | 3,740 | 3,740 | 3,700 | 3,705 | -5 | -0.1% | 74,300 |
| 2023/03/03 | 3,695 | 3,740 | 3,695 | 3,710 | +50 | +1.4% | 155,200 |
| 2023/03/02 | 3,650 | 3,675 | 3,630 | 3,660 | +40 | +1.1% | 96,400 |
| 2023/03/01 | 3,620 | 3,640 | 3,610 | 3,620 | -5 | -0.1% | 73,200 |
| 2023/02/28 | 3,650 | 3,665 | 3,620 | 3,625 | -40 | -1.1% | 100,400 |
| 2023/02/27 | 3,630 | 3,665 | 3,630 | 3,665 | +40 | +1.1% | 46,600 |
| 2023/02/24 | 3,615 | 3,635 | 3,605 | 3,625 | +20 | +0.6% | 42,000 |
| 2023/02/22 | 3,635 | 3,635 | 3,595 | 3,605 | -30 | -0.8% | 66,300 |
| 2023/02/21 | 3,625 | 3,640 | 3,620 | 3,635 | -5 | -0.1% | 51,100 |
| 2023/02/20 | 3,660 | 3,670 | 3,640 | 3,640 | +15 | +0.4% | 52,900 |
| 2023/02/17 | 3,620 | 3,625 | 3,610 | 3,625 | -10 | -0.3% | 35,600 |
| 2023/02/16 | 3,640 | 3,660 | 3,630 | 3,635 | -5 | -0.1% | 55,400 |
| 2023/02/15 | 3,630 | 3,650 | 3,580 | 3,640 | +30 | +0.8% | 101,700 |
| 2023/02/14 | 3,600 | 3,615 | 3,585 | 3,610 | +30 | +0.8% | 50,100 |
| 2023/02/13 | 3,605 | 3,615 | 3,575 | 3,580 | -5 | -0.1% | 35,500 |
| 2023/02/10 | 3,580 | 3,605 | 3,570 | 3,585 | ±0 | ±0% | 52,400 |
| 2023/02/09 | 3,595 | 3,615 | 3,580 | 3,585 | -30 | -0.8% | 38,300 |
| 2023/02/08 | 3,600 | 3,635 | 3,600 | 3,615 | +35 | +1% | 53,400 |
| 2023/02/07 | 3,575 | 3,620 | 3,565 | 3,580 | +35 | +1% | 59,500 |
| 2023/02/06 | 3,665 | 3,680 | 3,545 | 3,545 | -85 | -2.3% | 142,800 |
| 2023/02/03 | 3,660 | 3,680 | 3,575 | 3,630 | -60 | -1.6% | 178,300 |
| 2023/02/02 | 3,715 | 3,735 | 3,690 | 3,690 | -40 | -1.1% | 75,300 |
| 2023/02/01 | 3,780 | 3,780 | 3,730 | 3,730 | -35 | -0.9% | 35,200 |
| 2023/01/31 | 3,750 | 3,785 | 3,750 | 3,765 | +10 | +0.3% | 69,700 |
| 2023/01/30 | 3,755 | 3,765 | 3,735 | 3,755 | -20 | -0.5% | 53,200 |
| 2023/01/27 | 3,780 | 3,790 | 3,765 | 3,775 | -10 | -0.3% | 32,700 |
| 2023/01/26 | 3,805 | 3,810 | 3,765 | 3,785 | -30 | -0.8% | 57,600 |
| 2023/01/25 | 3,810 | 3,835 | 3,780 | 3,815 | -10 | -0.3% | 47,500 |
501～
550
件表示中 / 3685件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 414,000円 | +30.5% | +111.0% | 4.59% | 11.67倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 住友ファーマ | 61,900円 | +21.1% | - | 0.00% | 15.37倍 | 2.15倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 187,700円 | +5.0% | +1.5% | 0.00% | 16.11倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 383,500円 | +14.5% | -2.3% | 2.35% | 14.03倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 228,200円 | - | - | 0.00% | - | 105.70倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
